Other Content - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Other Content

Pfizer Restructuring a Boon to CMOs and CROs

March 2, 2007

Pharmaceutical Technology

As big pharmaceutical companies restructure and reevaluate the way they do business, contract research and manufacturing organizations could reap greater financial rewards.

Will Delivery Technologies Deliver Profits to CMOs?...

October 2, 2006

Special from Pharmaceutical Technology

More CMOs look to proprietary delivery technologies to enhance profitability.

First Impressions...

July 2, 2006

Special from Pharmaceutical Technology

China is on the rise as a center for pharmaceutical R&D, but companies are still getting their footing for operating in China and the services industry has some maturing to do.

Here's to a Strong 2006!

January 1, 2006

Pharmaceutical Technology

The big question for pharmaceutical services providers coming into 2006 is: will the good times continue to roll?

Compounding Pharmacies' Lawsuit Against FDA Will Continue

May 27, 2005
Pharmaceutical Technology

Compounding Pharmacies' Lawsuit Against FDA Will Continue

Outsourcing Outlook

June 1, 2002

Pharmaceutical Technology

The author discusses the upcoming human research congressional debate and CROs' preparations to respond.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Click here